Enanta Pharmaceuticals Inc (ENTA) — Free Cash Flow Generation Index
Enanta Pharmaceuticals Inc (ENTA) has a Free Cash Flow Generation Index of 0.99x as of June 2025. Free cash flow of $17.35 Million represents 1% of operating cash flow ($17.51 Million). Explore capital reinvestment ratio of Enanta Pharmaceuticals Inc to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Enanta Pharmaceuticals Inc Free Cash Flow Generation Index (2011–2020)
Historical FCF Generation Index trend for Enanta Pharmaceuticals Inc across 10 annual periods. For the full cash flow conversion analysis, see Enanta Pharmaceuticals Inc (ENTA) cash flow conversion.
Annual Free Cash Flow Generation for Enanta Pharmaceuticals Inc (2011–2020)
Year-by-year Free Cash Flow Generation Index for Enanta Pharmaceuticals Inc. Check Enanta Pharmaceuticals Inc (ENTA) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2020 | 0.80x | $5.64 Million | $7.09 Million | $1.45 Million | ▼ -13.9% |
| 2019 | 0.92x | $66.00 Million | $71.42 Million | $5.42 Million | ▲ +2.9% |
| 2018 | 0.90x | $26.24 Million | $29.22 Million | $2.98 Million | ▼ -5.7% |
| 2017 | 0.95x | $50.15 Million | $52.65 Million | $2.51 Million | ▲ +9.8% |
| 2016 | 0.87x | $31.07 Million | $35.81 Million | $4.74 Million | ▼ -10.5% |
| 2015 | 0.97x | $74.34 Million | $76.67 Million | $2.34 Million | ▲ +2.2% |
| 2014 | 0.95x | $19.15 Million | $20.18 Million | $1.03 Million | ▲ +0.6% |
| 2013 | 0.94x | $10.05 Million | $10.65 Million | $606.00K | ▼ -4.6% |
| 2012 | 0.99x | $22.37 Million | $22.62 Million | $252.00K | ▲ +0.8% |
| 2011 | 0.98x | $23.57 Million | $24.02 Million | $445.00K | — |